CAS: 1416334-69-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK-A1 REF: 7W-GW0843CAS: 1416334-69-4 | - - - | 331.00 €~964.00 € | Thu 30 Jan 25 |
 | GSK-A1 REF: TM-T27499CAS: 1416334-69-4 | 98.97% | To inquire | Thu 30 Jan 25 |
 | Pi4Ka inhibitor-A1 REF: 3D-RGC33469CAS: 1416334-69-4 | Min. 95% | 10,931.00 €~18,217.00 € | Thu 06 Mar 25 |
Ref: 7W-GW0843
| 1mg | 331.00 € | ||
| 5mg | 656.00 € | ||
| 10mg | 964.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025
GSK-A1
CAS:1416334-69-4
GSK-A1 is a specific inhibitor of PI4KA, also inhibited calcium-driven PRL secretion without affecting calcium …
Formula:
C29H27FN6O4S
Purity:
98.97%
Color and Shape:
Solid
Molecular weight:
574.63
Ref: TM-T27499
| 1mg | 78.00 € | ||
| 5mg | 162.00 € | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 30 Jan 2025
Pi4Ka inhibitor-A1
CAS:1416334-69-4
Pi4Ka inhibitor-A1 is a peptide that is used in research as an activator or inhibitor …
Formula:
C29H27FN6O4S
Purity:
Min. 95%
Molecular weight:
574.6 g/mol
Ref: 3D-RGC33469
| 1g | 18,217.00 € | ||
| 250mg | 10,931.00 € | ||
| 500mg | 11,538.00 € |
Estimated delivery in United States, on Thursday 6 Mar 2025
